Ask AI

Comprehensive Patient-Centric Care in Multiple Myeloma: Experts Unpack Challenges, Clinical Considerations, and Strategies to Optimize Care for Patients Treated With Bispecific Antibodies

Enhance your understanding of the safety and efficacy of bispecific antibodies used to treat patients with multiple myeloma to optimize outcomes through a certified roundtable video module, expert-written ClinicalThought commentary, certified text modules, and accompanying downloadable slides.

Share

Program Content

Activities

Adverse Events With Bispecific Antibodies in MM
APP Perspectives: Managing Toxicities With Bispecific Antibodies in Multiple Myeloma 
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 07, 2025

BsAb in MM Pharmacy
Clinical Considerations and Strategies to Optimize the Care of Patients With Multiple Myeloma Treated With Bispecific Antibodies: A Pharmacy Perspective
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 14, 2025

APP Perspectives Effective Use of Bispecific Antibodies in MM
APP Perspectives: BsAb in MM
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 17, 2025

Activities

BsAbs in Multiple Myeloma
Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma: A Roundtable of Considerations and Strategies for Implementation Into Clinical Practice
Video
Congratulations: You achieved a completion on 04/09/2022

Released: October 15, 2025

Expires: April 14, 2026

Activities

Bispecific Antibodies in MM
APP Perspectives: Managing Toxicities With Bispecific Antibodies in Multiple Myeloma
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: November 07, 2025

Expires: May 06, 2026

APP BsAb in MM
APP Perspectives: Safe and Effective Use of Bispecific Antibodies in Multiple Myeloma
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: November 17, 2025

Expires: May 16, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson